Author

P. High

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Azhdarinia· 1 shared C. Guernsey-Biddle· 1 shared H. Tran· 1 shared J. H. Rowe· 1 shared J. Jacob· 1 shared K. S. Carmon· 1 shared K. Tsuchikama· 1 shared S. AghaAmiri· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Azhdarinia

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer

J. Jacob, Y. Anami, P. High, Z. Liang, S. Subramanian, S. C. Ghosh, S. AghaAmiri, C. Guernsey-Biddle, H. Tran, J. H. Rowe, A. Azhdarinia, K. Tsuchikama, K. S. Carmon

This study develops and tests EREG-targeting ADCs showing efficacy in both RAS mutant and wildtype CRC, with high potency and safety in preclinical models.

bioRxiv · Feb 20, 2024 · PreprintCancer Biology